Clinical Application of 68Ga-PSMA PET in Prostate Cancer
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Aug 27, 2018
Trial Information
Current as of May 24, 2025
Unknown status
Keywords
ClinConnect Summary
Prostate cancer is the 7th leading cause of cancer death for men in Taiwan. It is important to identify the extent of disease extent to deliver adequate treatment, either for primary staging or in recurrence. However, conventional imaging techniques including computed tomography, bone scintigraphy, and immunoscintigraphy with 111In-capromab pendetide are not sensitive or specific enough to detect metastatic or recurrent disease. Although more widely applied, magnetic resonance still relies on size and shape criteria. 68Ga-PSMA is a new novel positron emission radiotracer which several preli...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Histologically confirmed prostate cancer
- Exclusion Criteria:
- • Patients with known malignancy in other organs.
- • Patients with severe claustrophobia or unstable vital sigh
- • Other serious comorbidities evaluated by primary investigator
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials